Treatment of Heart Failure with Reduced Ejection Fraction: Current Update / 대한내과학회지
Korean Journal of Medicine
;
: 127-134, 2015.
Artigo
em Coreano
| WPRIM
| ID: wpr-201034
ABSTRACT
The prevalence of heart failure (HF) has been steadily increasing and it now creates an enormous social and economic burden. HF is a syndrome characterized by a high mortality rate, frequent hospitalization, a reduced quality of life, and a complex therapeutic regimen. In the last three decades, major progress in both the diagnosis and management of HF has taken place, and the pharmacologic and non-pharmacologic advances have led to a significant improvement in survival and symptoms in HF patients. After an accurate diagnosis, a proper HF management plan requires a multi-level team approach comprised of the correct combination of drug therapy, device therapy, and surgery, including heart transplantation. In this review, we focused on the pharmacologic and non-pharmacologic treatment strategies for HF with reduced ejection fraction. The goal was to develop treatment guidelines based on significant evidence derived from large clinical trials.
Texto completo:
DisponíveL
Índice:
WPRIM (Pacífico Ocidental)
Assunto principal:
Qualidade de Vida
/
Prevalência
/
Mortalidade
/
Transplante de Coração
/
Diagnóstico
/
Tratamento Farmacológico
/
Insuficiência Cardíaca Sistólica
/
Insuficiência Cardíaca
/
Hospitalização
Tipo de estudo:
Estudo diagnóstico
/
Guia de Prática Clínica
/
Estudo de prevalência
/
Estudo prognóstico
Limite:
Humanos
Idioma:
Coreano
Revista:
Korean Journal of Medicine
Ano de publicação:
2015
Tipo de documento:
Artigo
Similares
MEDLINE
...
LILACS
LIS